Kineret subcutaneous: Uses | 合法藥品大搜索

Kineret is the only interleukin-1 receptor antagonist (IL-1Ra) that is FDA-approved to reduce the inflammation, joint pain, and joint swelling caused by ... Read More

KINERET® (anakinra) is a daily injection treatment for RA Information and resources to help you inject and store KINERET ... Read More

Get information about KINERET® (anakinra) as a treatment for RA, NOMID, and DIRA as well as patient support. Read Important Safety Information. Read More

The active substance in Kineret, anakinra, is an immunosuppressive medicine (a medicine that reduces the activity of the immune system). It is a copy of a ... Read More

2021年7月19日 — Kineret is an immunosuppressant (a medicine that reduces the activity of the immune system) currently authorised for the treatment of a number ... Read More

RA: Adults. The recommended dose of Kineret is 100 mg administered once a day by subcutaneous injection. The dose should be administered at approximately the ... Read More

Kineret (anakinra) is a recombinant, nonglycosylated form of the human interleukin-1 receptor antagonist (IL-1Ra). Kineret differs from native human IL-1Ra ... Read More

Kineret is indicated in adults for the treatment of the signs and symptoms of RA in combination with methotrexate, with an inadequate response to ... Read More

Find patient medical information for Kineret subcutaneous on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ... Read More